The bill HB 2517 mandates that the Arizona Health Care Cost Containment System (AHCCCS) provide comprehensive coverage for obesity treatment, which includes prevention and wellness, nutrition counseling, intensive behavioral therapy, bariatric surgery, and FDA-approved anti-obesity medications. The new language specifies that the coverage criteria for these medications cannot be more restrictive than the FDA-approved indications for their use. Additionally, the bill allows AHCCCS to utilize a prior authorization process to assess medical necessity for obesity treatment, ensuring that such determinations align with those for other medical conditions.

Furthermore, the bill requires AHCCCS to inform members about the coverage changes in writing, ensuring that this information is clearly presented in any correspondence sent to them. The definition of "FDA-approved anti-obesity medication" is also clarified to include any medication approved for chronic weight management in patients with obesity. This represents a significant shift from current law, which excludes coverage for weight loss medications, thereby expanding access to obesity treatment options for AHCCCS members.

Statutes affected:
Introduced Version: 36-2907.16